+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Bio-Manufacturing Market By Product Type (Antibodies (MoAb), Cytokines, Enzymes, Fusion Proteins, Others), By Source, By Method, By Equipment, By Type, By Technology, By Application,By End User, By Region, Competition, Forecast & Opportunities, 2025

  • PDF Icon

    Report

  • May 2020
  • Region: Global
  • TechSci Research
  • ID: 5022679
UP TO OFF until Dec 31st 2022
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Bio-manufacturing Market is expected to grow at a robust pace over the next five years, driven by the rising prevalence of various chronic diseases such as diabetes, cancer, among others. This has been significantly augmenting the demand for effective and faster treatment of these diseases, which in turn is expected to positively influence the bio-manufacturing market. Additionally, increase in the approvals of biologics is further expected to propel the market during forecast period. Furthermore, increasing expenditure by various governments and major market players and adoption of advanced biomanufacturing strategies to increase the development pipeline of drugs, vaccines, enzymes, among others is expected to foster the market growth through 2025. However, the associated risk of product contamination can hamper the market growth. Also, strict regulatory framework regarding GMP can impede the market growth over next few years.

The Global Bio-manufacturing Market is segmented based on product type, source, method, equipment, type, technology, application, end-user, and region. Based on product type, the market can be fragmented into antibodies (MoAb), cytokines, enzymes, fusion proteins, hormones, recombinant proteins and others. The monoclonal antibodies segment is expected to dominate the market over the next five years. Additionally, various monoclonal antibodies such as Humira, Remicade, Enbrel, Rituxan, Avastin and Herceptin are available in the market since 2015 which were manufactured using bio-manufacturing process and are doing very well in the market. Also, various monoclonal antibodies are in BLA or equivalent stages thereby driving the growth of the segment. Based on technology, the market can be categorized into downstream processing, upstream processing, integrated and single use. The single use segment is expected to witness significant growth on account of the associated benefits such as reduced risk of contamination, higher flexibility in multiproduct facilities, cost-effectiveness, among others. Based on end-user, the market can be segmented into biotechnology & biopharmaceutical companies, CMOs, CROs, CDMOs and others. The CMOs are expected to dominate the market through 2025 due to anticipated increase in the demand for clinical and commercial supply of biologics.

Among all the regions, Asia Pacific is expected to witness significant growth in its bio-manufacturing market owing to the increasing healthcare expenditure by the government and various public-private players, especially in countries like China and India. This has allowed a lot of domestic pharmaceutical companies in these countries to develop a range of biologic products such as monoclonal antibodies, recombinant proteins, among others. Additionally, most of the major players operating in the market are expanding in Asia Pacific due to availability of low cost labor as well as manufacturing facilities, thereby creating lucrative opportunities.

Major players operating in the Global Bio-manufacturing Market include Abbott Laboratories, Abzena Ltd., AGC Biologics GmbH, Althea Inc., Amgen Inc., Asymchem Laboratories Inc., Baxter Biopharma Solutions LLC, Biocon Ltd., Biogen Inc., Boehringer Ingelheim GmbH, Celgene Corporation, Danaher Corporation, Fujifilm Diosynth Biotechnologies, Gilead Sciences, Inc, Lonza Group, MicroProtein Technologies, Inc., Novo Nordisk, Patheon N.V. (Thermo Fischer Scientific), Proteogenix Inc., Proteus Digital Health Inc., among others.

Years considered for this report:
  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021–2025

Objective of the Study:
  • To analyze and estimate the market size of the Global Bio-manufacturing Market from 2015 to 2018.
  • To estimate and forecast the market size of the Global Bio-manufacturing Market from 2019 to 2025.
  • To classify and forecast the Global Bio-manufacturing Market based on product type, source, method, equipment, type, technology, application, end-user, and regional distribution.
  • To identify dominant region or segment in the Global Bio-manufacturing Market.
  • To identify drivers and challenges for the Global Bio-manufacturing Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Bio-manufacturing Market.
  • To identify and analyze the profile of leading players operating in the Global Bio-manufacturing Market.
  • To identify key sustainable strategies adopted by market players in the Global Bio-manufacturing Market.

The author performed both primary as well as exhaustive secondary research for this study. Initially, researchers sourced a list of market players operating across the globe. Subsequently, researchers conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, researchers could include the companies which could not be identified due to the limitations of secondary research. The author analyzed the manufacturers, distribution channels and presence of all major players across the globe.

The author calculated the market size of the Global Bio-manufacturing Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. Researchers sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • Bio-manufacturing companies and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to bio-manufacturing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:
In this report, the Global Bio-manufacturing Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
  • By Product Type:
  • Antibodies (MoAb)
  • Cytokines
  • Enzymes
  • Fusion Proteins
  • Hormones
  • Recombinant Proteins
  • Others
  • By Source:
  • Microbial Culture
  • Plant-Based
  • Animal-Based
  • By Method:
  • Cell Culture
  • Mammalian
  • Microbial
  • Blood Plasma Fractionation
  • Column Chromatography
  • Homogenization
  • Others
  • By Equipment:
  • Plastic
  • Steel
  • By Type:
  • Reusable
  • Disposable
  • Automated
  • Manual
  • By Technology:
  • Downstream Processing
  • Upstream Processing
  • Integrated
  • Single Use
  • By Application:
  • Diagnostics
  • Therapeutics
  • By End-User:
  • Biotechnology & Biopharmaceutical Companies
  • CMOs
  • CROs
  • CDMOs
  • Others
  • By Region:
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • South America
  • Brazil
  • Argentina
  • Colombia

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Bio-manufacturing Market.

Available Customizations:
With the given market data, researchers offers customizations according to a company’s specific needs.

Table of Contents

1. Product Overview2. Research Methodology3. Impact of COVID-19 on Global Bio-Manufacturing Market4. Executive Summary5. Voice of Customer
6. Global Bio-Manufacturing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Antibodies (MoAb), Cytokines, Enzymes, Fusion Proteins, Hormones, Recombinant Proteins, Others)
6.2.2. By Source (Microbial Culture, Plant-Based, Animal-Based)
6.2.3. By Method (Cell Culture (Mammalian v/s Microbial), Blood Plasma Fractionation, Column Chromatography, Homogenization, Others)
6.2.4. By Equipment (Plastic v/s Steel)
6.2.5. By Type (Reusable, Disposable, Automated, Manual)
6.2.6. By Technology (Downstream Processing, Upstream Processing, Integrated, Single Use)
6.2.7. By Application (Diagnostics v/s Therapeutics)
6.2.8. By End User (Biotechnology & Biopharmaceutical Companies, CMOs, CROs, CDMOs, Others)
6.2.9. By Company (2019)
6.2.10. By Region
6.3. Product Market Map
7. Asia-Pacific Bio-Manufacturing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Source
7.2.3. By Method
7.2.4. By Equipment
7.2.5. By Type
7.2.6. By Technology
7.2.7. By Application
7.2.8. By End User
7.2.9. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China Bio-Manufacturing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Source
7.3.1.2.3. By Method
7.3.1.2.4. By Equipment
7.3.1.2.5. By Type
7.3.1.2.6. By Technology
7.3.1.2.7. By Application
7.3.1.2.8. By End User
7.3.2. India Bio-Manufacturing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Source
7.3.2.2.3. By Method
7.3.2.2.4. By Equipment
7.3.2.2.5. By Type
7.3.2.2.6. By Technology
7.3.2.2.7. By Application
7.3.2.2.8. By End User
7.3.3. Australia Bio-Manufacturing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Source
7.3.3.2.3. By Method
7.3.3.2.4. By Equipment
7.3.3.2.5. By Type
7.3.3.2.6. By Technology
7.3.3.2.7. By Application
7.3.3.2.8. By End User
7.3.4. Japan Bio-Manufacturing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Source
7.3.4.2.3. By Method
7.3.4.2.4. By Equipment
7.3.4.2.5. By Type
7.3.4.2.6. By Technology
7.3.4.2.7. By Application
7.3.4.2.8. By End User
7.3.5. South Korea Bio-Manufacturing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Source
7.3.5.2.3. By Method
7.3.5.2.4. By Equipment
7.3.5.2.5. By Type
7.3.5.2.6. By Technology
7.3.5.2.7. By Application
7.3.5.2.8. By End User
8. Europe Bio-Manufacturing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Source
8.2.3. By Method
8.2.4. By Equipment
8.2.5. By Type
8.2.6. By Technology
8.2.7. By Application
8.2.8. By End User
8.2.9. By Country
8.3. Europe: Country Analysis
8.3.1. France Bio-Manufacturing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Source
8.3.1.2.3. By Method
8.3.1.2.4. By Equipment
8.3.1.2.5. By Type
8.3.1.2.6. By Technology
8.3.1.2.7. By Application
8.3.1.2.8. By End User
8.3.2. Germany Bio-Manufacturing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Source
8.3.2.2.3. By Method
8.3.2.2.4. By Equipment
8.3.2.2.5. By Type
8.3.2.2.6. By Technology
8.3.2.2.7. By Application
8.3.2.2.8. By End User
8.3.3. United Kingdom Bio-Manufacturing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Source
8.3.3.2.3. By Method
8.3.3.2.4. By Equipment
8.3.3.2.5. By Type
8.3.3.2.6. By Technology
8.3.3.2.7. By Application
8.3.3.2.8. By End User
8.3.4. Italy Bio-Manufacturing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Source
8.3.4.2.3. By Method
8.3.4.2.4. By Equipment
8.3.4.2.5. By Type
8.3.4.2.6. By Technology
8.3.4.2.7. By Application
8.3.4.2.8. By End User
8.3.5. Spain Bio-Manufacturing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Source
8.3.5.2.3. By Method
8.3.5.2.4. By Equipment
8.3.5.2.5. By Type
8.3.5.2.6. By Technology
8.3.5.2.7. By Application
8.3.5.2.8. By End User
9. North America Bio-Manufacturing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Source
9.2.3. By Method
9.2.4. By Equipment
9.2.5. By Type
9.2.6. By Technology
9.2.7. By Application
9.2.8. By End User
9.2.9. By Country
9.3. North America: Country Analysis
9.3.1. United States Bio-Manufacturing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Source
9.3.1.2.3. By Method
9.3.1.2.4. By Equipment
9.3.1.2.5. By Type
9.3.1.2.6. By Technology
9.3.1.2.7. By Application
9.3.1.2.8. By End User
9.3.2. Mexico Bio-Manufacturing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Source
9.3.2.2.3. By Method
9.3.2.2.4. By Equipment
9.3.2.2.5. By Type
9.3.2.2.6. By Technology
9.3.2.2.7. By Application
9.3.2.2.8. By End User
9.3.3. Canada Bio-Manufacturing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Source
9.3.3.2.3. By Method
9.3.3.2.4. By Equipment
9.3.3.2.5. By Type
9.3.3.2.6. By Technology
9.3.3.2.7. By Application
9.3.3.2.8. By End User
10. South America Bio-Manufacturing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Source
10.2.3. By Method
10.2.4. By Equipment
10.2.5. By Type
10.2.6. By Technology
10.2.7. By Application
10.2.8. By End User
10.2.9. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Bio-Manufacturing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Source
10.3.1.2.3. By Method
10.3.1.2.4. By Equipment
10.3.1.2.5. By Type
10.3.1.2.6. By Technology
10.3.1.2.7. By Application
10.3.1.2.8. By End User
10.3.2. Argentina Bio-Manufacturing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Source
10.3.2.2.3. By Method
10.3.2.2.4. By Equipment
10.3.2.2.5. By Type
10.3.2.2.6. By Technology
10.3.2.2.7. By Application
10.3.2.2.8. By End User
10.3.3. Colombia Bio-Manufacturing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Source
10.3.3.2.3. By Method
10.3.3.2.4. By Equipment
10.3.3.2.5. By Type
10.3.3.2.6. By Technology
10.3.3.2.7. By Application
10.3.3.2.8. By End User
11. Middle East and Africa Bio-Manufacturing Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product Type
11.2.2. By Source
11.2.3. By Method
11.2.4. By Equipment
11.2.5. By Type
11.2.6. By Technology
11.2.7. By Application
11.2.8. By End User
11.2.9. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Bio-Manufacturing Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product Type
11.3.1.2.2. By Source
11.3.1.2.3. By Method
11.3.1.2.4. By Equipment
11.3.1.2.5. By Type
11.3.1.2.6. By Technology
11.3.1.2.7. By Application
11.3.1.2.8. By End User
11.3.2. Saudi Arabia Bio-Manufacturing Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product Type
11.3.2.2.2. By Source
11.3.2.2.3. By Method
11.3.2.2.4. By Equipment
11.3.2.2.5. By Type
11.3.2.2.6. By Technology
11.3.2.2.7. By Application
11.3.2.2.8. By End User
11.3.3. UAE Bio-Manufacturing Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product Type
11.3.3.2.2. By Source
11.3.3.2.3. By Method
11.3.3.2.4. By Equipment
11.3.3.2.5. By Type
11.3.3.2.6. By Technology
11.3.3.2.7. By Application
11.3.3.2.8. By End User
11.3.4. Kuwait Bio-Manufacturing Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Product Type
11.3.4.2.2. By Source
11.3.4.2.3. By Method
11.3.4.2.4. By Equipment
11.3.4.2.5. By Type
11.3.4.2.6. By Technology
11.3.4.2.7. By Application
11.3.4.2.8. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
13.1. Cell Line Engineering
13.2. Disposable Manufacturing Technology
13.3. Perfusion Culture
13.4. In-Silico Modelling
13.5. Modular Factories
14. Patent Analysis
15. Competitive Landscape
15.1. Competition Outlook
15.2. Company Profiles
15.3. Company Details
15.4. Financials (As Reported)
15.5. Supply/ Value Chain Analysis
15.6. SWOT Analysis
15.7. Key Market Focus and Geographical Presence
15.8. Planned Investments
15.9. Market Positioning
15.10. Import Export Analysis (By Region)
15.11. Pricing Analysis (By Country)
15.12. Leading Players Profiled
15.12.1. Abbott Laboratories
15.12.2. Abzena Ltd.
15.12.3. AGC Biologics GmbH
15.12.4. Althea Inc.
15.12.5. Amgen Inc.
15.12.6. Asymchem Laboratories Inc.
15.12.7. Baxter Biopharma Solutions LLC
15.12.8. Biocon Ltd.
15.12.9. Biogen Inc.
15.12.10. Boehringer Ingelheim GmbH
15.12.11. Celgene Corporation
15.12.12. Danaher Corporation
15.12.13. Fujifilm Diosynth Biotechnologies
15.12.14. Gilead Sciences, Inc
15.12.15. Lonza Group
15.12.16. MicroProtein Technologies, Inc.
15.12.17. Novo Nordisk
15.12.18. Patheon N.V. (Thermo Fischer Scientific)
15.12.19. Proteogenix Inc.
15.12.20. Proteus Digital Health Inc.
16. Strategic Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Abzena Ltd.
  • AGC Biologics GmbH
  • Althea Inc.
  • Amgen Inc.
  • Asymchem Laboratories Inc.
  • Baxter Biopharma Solutions LLC
  • Biocon Ltd.
  • Biogen Inc.
  • Boehringer Ingelheim GmbH
  • Celgene Corporation
  • Danaher Corporation
  • Fujifilm Diosynth Biotechnologies
  • Gilead Sciences, Inc
  • Lonza Group
  • MicroProtein Technologies, Inc.
  • Novo Nordisk
  • Patheon N.V. (Thermo Fischer Scientific)
  • Proteogenix Inc.
  • Proteus Digital Health Inc.